| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.4 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |